News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Seyed Alireza Javadinia: Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous SCC
Seyed Alireza Javadinia/LinkedIn
Apr 6, 2025, 10:38

Seyed Alireza Javadinia: Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous SCC

Seyed Alireza Javadinia, V, shared an article by Paolo Bossi, et al. on LinkedIn:

“The I-TACKLE trial by Paolo Bossi; Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous SCC:

Median treatment durations were 3 months (pembrolizumab) and 4 months (combination).

Highlights:

1. Cetuximab overcame pembrolizumab resistance, reaching a 63 % cumulative ORR.
2. Cetuximab reversed primary/acquired resistance in 43 % of cSCC cases, with safety.”

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial.

Authors: Paolo Bossi, et al.

Seyed Alireza Javadinia: Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous SCC

cancer cetuximab fight against cancer Global fight against cancer I-TACKLE trial immunotherapy metastatic cutaneous SCC OncoDaily Oncology Paolo Bossi pembrolizumab Sabzevar University of Medical Sciences Seyed Alireza Javadinia
Special Coverage
Blog
May 30, 2025, 01:27
$225,000 AACR Gertrude B. Elion Award Supports Junior Faculty Cancer Research - AACR
Blog
May 30, 2025, 01:15
Lung cancer is now the leading cause of cancer death among women worldwide - UICC
Blog
May 30, 2025, 01:04
Monica Kraft: New Evidence Supports As-Needed Albuterol and Budesonide for Mild Asthma
Blog
May 30, 2025, 00:42
Advocating for Better Brain Cancer Care in Regional NSW - Mark Hughes Foundation Centre for Brain Cancer Research
Blog
May 30, 2025, 00:25
Jérôme Salomon: Countries Agree to Update Global Action Plan to Reduce Deaths from Antimicrobial Resistance
Blog
May 29, 2025, 23:20
Alvaro Lassalet: Honored to Join as Associate Editor for Neuro-oncology Pediatrics Journal
Blog
May 29, 2025, 22:49
European Liver Patients'​ Association: The Role of Research and Innovation in Advancing Liver Cancer Therapies
Opinion
May 29, 2025, 22:38
Prerana Jha on ctDNA Molecular Profiling in Indian Lung Cancer Patients Study
Blog
May 29, 2025, 22:33
Ash Tewari Discusses Prostate Cancer Risk and Screening Guidelines - Mount Sinai Department of Medicine
Insight
May 29, 2025, 22:26
Alberto Puccini Shared Insights from AACR 2025 Update at Bari Congress
Blog
May 29, 2025, 22:19
Wafaa M Rashed Highlights PAPERI Blog on Prenatal Genetic Testing Policy in Africa by Mutaz Mohammed
Opinion
May 29, 2025, 22:12
ELPA Highlight Liver Cancer Awareness and Prevention During European Week Against Cancer